Freedom’s Shares Uplifted On ASX Despite Announcing Expected EBITDA Loss Of $9Mn– $10Mn

Freedom’s Shares Uplifted On ASX Despite Announcing Expected EBITDA Loss Of $9Mn– $10Mn

Australian-based specialist risk insurance company Freedom Insurance Group Ltd (ASX: FIG) shares uplifted by 5 percent on 21 December 2018 after proving an update on its earnings expectations for the half year ending 31 December 2018.

The company is expecting an EBITDA loss of between $9.0 million and $10.0 million for the six months ended 31 December 2018. Earlier the company was expecting EBITDA loss of between $7.0 million and $8.0 million. The lower than anticipated net Revenue, higher commission clawbacks and higher one-off external consultant costs are the main reasons behind this increase in the expected loss. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Recently on 6 December 2018, the company announced the completion of the strategic review process which was undertaken to examine the company’s business structure and operating model in light of ASIC’s recommendations. As part of the review, the Board found out that, the company might face a liquidity shortfall during CY 2019 due to the timing of payments of commission clawbacks in the absence of receipts of commissions from new business sales. Currently, the company is evaluating various alternative options to solve this problem of potential shortfall. Further, the company is also implementing initiatives to improve operational efficiency and reduce costs.

In the 2018 financial year, the company reported Net revenue of $64.1 million which was 20 higher than the previous corresponding period (pcp). The Group’s revenue includes a mix of commission revenue which includes upfront commission and fees generated by policy sale and ongoing commission and fees; net present value trail commission movement and administration fees related to the ‘in force’ book of policies. The company also reported an EBITDA of $18.7 million which includes $3.3mn profit on the sale of the Noble Oak shareholding, and $1.7mn in transaction related costs. The company earned a Net Profit After Tax (NPAT) of $13.2 million which was 6% less than pcp.

The company’s sales were affected in the first half of FY 2018 due to the lead quality and sales conversion issues; however, after the implementation of various operational improvements, sales productivity recovered in the second half. Total sales in the second half of $32.8 million, were 0.5 percent higher than the second half of FY17. During the financial year 2018, the total number of customer grew by 24 percent to 357k and in force premiums increased by 14 percent to $124.6 million, supported by sales and customer retention results. Higher in force premiums contributed to a $4.0 million increase in trail commissions and administration fees and a $30.2 million increase in the value of the trail asset to $72.8 million.

In the last six months, the share price of the company decreased by 95.60 percent as on 20 December 2018 and traded at a PE ratio of 0.360x. FIG’s shares traded at $0.021 with a market capitalization of circa $4.79 million as on 21 December 2018 (AEST 4:00 Pm).


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report